id,question,syntactic_valid,execution_success,result_match,gold_rows,gen_rows,error
F1.4-000157-P4,Enumerate the variants linked to PSMA1.,✓,✓,✓,0,0,
F1.4-000057-P1,What variants are known for the MT-ND6 gene?,✓,✓,✓,0,0,
F6.1-000029-P1,"In Lung Non-small Cell Carcinoma, which genes confer resistance to Durvalumab or Dacomitinib?",✓,✓,✓,2,2,
F6.1-000155-S1,Which genes predict resistance to Olaparib or Afimoxifene in Malignant Tumor Of The Breast?,✓,✓,✗,3,0,
F6.1-000121-P2,List resistance genes for Paclitaxel or Brigatinib in Cancer.,✓,✓,✓,9,9,
F6.1-000161-S1-P1,"In Malignant Tumor Of The Breast, which genes confer resistance to Pan-AKT Kinase Inhibitor GSK690693 or Aromatase Inhibitor?",✓,✓,✗,3,0,
F6.2-000134-S1,"What therapies target TOP1 but NOT CTLA4, and have biomarker evidence in Carcinoma Of Colon?",✓,✓,✓,1,1,
F6.2-000096-S1,"What therapies target TOP1 but NOT PSMA3, and have biomarker evidence in Carcinoma Of Colon?",✓,✓,✓,1,1,
F6.2-000198-S1-P2,List therapies targeting TOP1 (not PTK6) with evidence in Carcinoma Of Colon.,✓,✓,✗,1,0,
F6.2-000109-S1-P2,List therapies targeting TOP1 (not PSMB6) with evidence in Carcinoma Of Colon.,✓,✓,✗,1,1,
F6.2-000182-S1-P1,Which drugs hit TOP1 but not TACSTD2 with evidence in Colonic Carcinoma?,✓,✓,✗,1,0,
F5.2-000055-S2-P2,Show drugs with variant-based evidence in Primary Myelofibrosis.,✓,✓,✗,2,0,
F5.2-000073-S1-P3,List treatments supported by variant evidence in Osteogenic Sarcoma.,✓,✓,✗,9,0,
F5.2-000083,List therapies with variant-level biomarkers in Breast Angiosarcoma.,✓,✓,✓,1,1,
F2.2-000166-P2,List genes associated with resistance to Imatinib Mesylate in Acute Myeloid Leukemia.,✓,✓,✓,1,1,
F2.2-000101-P3,What genes are resistance biomarkers for Foretinib in Lung Non-small Cell Carcinoma?,✓,✓,✓,1,1,
F2.2-000069-S1-P2,List genes associated with resistance to Radiation Therapy in Squamous Cell Carcinoma Of The Head And Neck.,✓,✗,✗,1,0,"PipelineError: Neo4j execution failed: CypherSyntaxError: {neo4j_code: Neo.ClientError.Statement.SyntaxError} {message: Invalid input '|': expected an expression, ')' or ',' (line 31, column 73 (offset: 1117))
""  collect(DISTINCT p IN reduce(acc = [], l IN all_pmid_lists | acc + l) | p) AS pmids""
                                                                         ^} {gql_status: 42001} {gql_status_description: error: syntax error or access rule violation - invalid syntax}"
F2.2-000093-P2,List genes associated with resistance to Multikinase Inhibitor AEE788 in Cancer.,✓,✓,✓,2,2,
F2.2-000073-S1,How does the variant SQSTM1 SQSTM1::NTRK1 Fusion affect response to Larotrectinib in Bronchogenic Lung Adenocarcinoma?,✓,✓,✗,1,0,
F2.2-000076-P1,What is the effect of MTAP Deletion on Anvumetostat in Solid Tumor?,✓,✓,✓,1,1,
F2.2-000077-S2,How does the variant KRAS G12C affect response to Trametinib in Non-small Cell Lung Cancer?,✓,✓,✗,1,0,
F2.2-000085-P3,How does MET Amplification AND MET Splice Site (c.3028G>A) influence response to Crizotinib for Lung Non-small Cell Carcinoma?,✓,✓,✗,1,2,
F4.1-000114-S2-P3,Show treatments hitting AKT1 that have biomarker evidence in Conventional (Clear Cell) Renal Cell Carcinoma.,✓,✓,✗,1,0,
F4.1-000034-S2-P1,What drugs targeting ALK have biomarker evidence in Naevocarcinoma?,✓,✓,✗,10,0,
F4.1-000048-S1-P1,What drugs targeting ALK have biomarker evidence in Tumor Of Soft Tissue And Skeleton?,✓,✓,✗,11,0,
F4.1-000114-S1-P3,Show treatments hitting AKT1 that have biomarker evidence in Clear Cell Kidney Carcinoma.,✓,✓,✗,1,0,
F2.2-000007-S1,Which genes affect response to Infigratinib in Connective And Soft Tissue Neoplasm?,✓,✓,✗,1,0,
F2.2-000095,Which genes affect response to Onartuzumab in Gastric Adenocarcinoma?,✓,✓,✗,1,1,
F2.2-000126-S1-P2,Which genes influence response to Fexagratinib for Non-small Cell Lung Cancer?,✓,✓,✗,1,0,
F2.2-000075-S1-P3,List genes with evidence affecting Dinaciclib in Serous Cystadenoma.,✓,✓,✗,1,0,
F6.4-000051-S2-P2,Which treatments target resistance biomarkers for Entrectinib in Primary Cancer?,✓,✓,✓,0,0,
F6.4-000176-S1-P3,Find alternative therapies targeting resistance genes for U0126 in Malignant Melanoma Of Skin Of Lower Limb.,✓,✓,✗,26,0,
F6.4-000165-S1-P1,"In Malignant Neoplasm Of Breast, what therapies target genes linked to resistance to Alpelisib?",✓,✓,✓,0,0,
F6.4-000199-S2-P2,Which treatments target resistance biomarkers for Trametinib in Naevocarcinoma?,✓,✓,✗,70,0,
F1.3-000056-P3,Identify the gene for the variant VHL Deletion AND R69C (c.205C>T).,✓,✓,✗,1,49,
F1.3-000062-P2,BRCA1 Mutation OR BRCA2 Mutation is a variant of what gene?,✓,✓,✗,1,2,
F2.2-000021-P1,What is the effect of BRAF V600R on Dabrafenib in Skin Melanoma?,✓,✓,✓,1,1,
F2.2-000158-S1-P1,What is the effect of IDH2 Mutation on Venetoclax in Acute Myelogenous Leukaemia?,✓,✓,✗,1,0,
F2.2-000200-P1,What is the effect of KIT Y553_W557DELYEVQW on Sunitinib in Gastrointestinal Stromal Tumor?,✓,✓,✓,1,1,
F2.2-000172-S2-P3,How does EGFR VIII influence response to Pacritinib for Adult Glioblastoma Multiforme?,✓,✓,✗,1,0,
F4.2-000032-P3,Find therapies that target resistance genes for Cisplatin in Transitional Cell Carcinoma.,✓,✗,✗,11,0,"PipelineError: Neo4j execution failed: CypherSyntaxError: {neo4j_code: Neo.ClientError.Statement.SyntaxError} {message: Invalid input 'GROUP': expected ',', 'ORDER BY', 'CALL', 'CREATE', 'LOAD CSV', 'DELETE', 'DETACH', 'FINISH', 'FOREACH', 'INSERT', 'LIMIT', 'MATCH', 'MERGE', 'NODETACH', 'OFFSET', 'OPTIONAL', 'REMOVE', 'RETURN', 'SET', 'SKIP', 'UNION', 'UNWIND', 'USE', 'WHERE', 'WITH' or <EOF> (line 19, column 1 (offset: 900))
""GROUP BY gene_symbol_for_agg, disease_name_for_agg""
 ^} {gql_status: 42001} {gql_status_description: error: syntax error or access rule violation - invalid syntax}"
F4.2-000199-S2-P2,Which drugs target biomarkers of resistance to Selpercatinib in Non-small Cell Lung Carcinoma?,✓,✓,✗,2,4,
F4.2-000189-P2,Which drugs target biomarkers of resistance to PLX4720 in Skin Melanoma?,✓,✓,✓,0,0,
F4.2-000072-S1-P1,"In Spongioblastoma Multiforme, what therapies target genes causing resistance to Palbociclib?",✓,✗,✗,0,0,"PipelineError: Neo4j execution failed: CypherSyntaxError: {neo4j_code: Neo.ClientError.Statement.SyntaxError} {message: Invalid input 'WHEN': expected an expression, ',', 'AS', 'ORDER BY', 'CALL', 'CREATE', 'LOAD CSV', 'DELETE', 'DETACH', 'FINISH', 'FOREACH', 'INSERT', 'LIMIT', 'MATCH', 'MERGE', 'NODETACH', 'OFFSET', 'OPTIONAL', 'REMOVE', 'RETURN', 'SET', 'SKIP', 'UNION', 'UNWIND', 'USE', 'WITH' or <EOF> (line 35, column 9 (offset: 1421))
""        WHEN size(coalesce(r.ref_sources, [])) > 0 AND size(coalesce(r.ref_sources, [])) = size(coalesce(r.ref_ids, []))""
         ^} {gql_status: 42001} {gql_status_description: error: syntax error or access rule violation - invalid syntax}"
F1.2-000166-P2,List genes that Fedratinib targets.,✓,✓,✓,2,2,
F1.2-000039-P4,What genes does Elacestrant affect?,✓,✓,✗,1,2,
F3.2-000111,What therapies target both HDAC1 and HDAC3?,✓,✓,✗,10,5,
F3.2-000129-P2,List therapies that hit HDAC11 and HDAC4.,✓,✓,✓,6,6,
F6.3-000001-S2-P3,Show therapies for EGFR where variants cause resistance in Non-small Cell Lung Carcinoma.,✓,✓,✗,31,35,
F6.3-000020,Find therapies that target TYMS for variants that cause resistance in Cancer.,✓,✓,✓,1,1,
F6.3-000186-P2,List drugs targeting PDGFRB with resistant variants in Acute Myeloid Leukemia.,✓,✓,✗,0,27,
F6.3-000068-S1-P3,Show therapies for ABL1 where variants cause resistance in Gastrointestinal Stromal Tumour.,✓,✓,✓,0,0,
F2.2-000085,Which genes predict sensitivity to Pexidartinib in Glioblastoma?,✓,✓,✓,1,1,
F2.2-000178,Which genes predict sensitivity to Erlotinib in High Grade Glioma?,✓,✓,✓,1,1,
F2.2-000136-P3,What genes are sensitivity biomarkers for Palbociclib in Cholangiocarcinoma?,✓,✓,✓,1,1,
F2.2-000187-S1-P1,Which genes confer sensitivity to Ponatinib in Acute Myeloblastic Leukemia?,✓,✓,✗,4,0,
F2.4-000097-P1,What consequence does the variant ERBB2 G776INSV_G/C have?,✓,✓,✗,1,1,
F2.4-000121-P3,What is the functional consequence of HRAS G13V?,✓,✓,✗,1,1,
F3.3-000118,Which drugs target TOP1 but not PSMC6?,✓,✓,✓,5,5,
F3.3-000106-P3,Show therapies for TOP1 but not for PSMB3.,✓,✓,✓,5,5,
F2.3-000087,Provide PMIDs supporting that KRAS G12D confers resistance to Sunitinib.,✓,✓,✓,1,1,
F2.3-000082-P2,What PMIDs support resistance of Gefitinib due to SMO Amplification?,✓,✓,✓,1,1,
F2.1-000170-P2,Describe how Ixazomib acts on PSMD3.,✓,✓,✓,1,1,
F2.1-000100-P3,What is Metformin's mechanism against NDUFAB1?,✓,✓,✓,2,2,
F5.1-000120-S1,"In Melanoma Of Eye, which biomarkers have evidence?",✓,✓,✗,1,0,
F5.1-000148-P2,List biomarkers with AFFECTS evidence in Lung Squamous Cell Carcinoma.,✓,✓,✓,12,12,
F5.1-000152-P3,What biomarkers have therapy response evidence in Childhood Pilocytic Astrocytoma?,✓,✓,✗,6,6,
F5.1-000087-P2,List biomarkers with AFFECTS evidence in Medullary Thyroid Carcinoma.,✓,✓,✓,20,20,
F2.3-000036,Provide PMIDs supporting that EGFR Exon 18 deletion confers sensitivity to Gefitinib.,✓,✓,✓,1,1,
F2.3-000183-P2,What PubMed IDs support sensitivity of Erlotinib due to EGFR A750T?,✓,✓,✓,1,1,
F3.1-000060-P2,List drugs for HDAC9 or HGF.,✓,✓,✓,4,4,
F1.1-000152,What drugs target BCL2?,✓,✓,✓,1,1,
F1.1-000187-P1,Which therapies target HTR3A?,✓,✓,✓,1,1,
F2.2-000035-S1,Which genes predict resistance to Aromatase Inhibitor in Mammary Tumor?,✓,✓,✗,2,0,
F2.2-000064-P2,Which genes influence response to MTOR Kinase Inhibitor AZD8055 for Breast Cancer?,✓,✓,✗,1,1,
F2.2-000185-P1,What genes are predictive biomarkers for Uprosertib in Melanoma?,✓,✓,✗,2,2,
F2.2-000091,How does the variant KRAS Mutation affect response to Pembrolizumab in Lung Non-small Cell Carcinoma?,✓,✓,✓,1,1,
F2.2-000040,Which genes affect response to Everolimus in Endometrial Carcinoma?,✓,✓,✗,1,1,
F2.2-000050-S2-P2,List genes associated with resistance to Ipilimumab in Malignant Tumor.,✓,✓,✗,1,0,
F5.1-000164-S1,"In Malignant Melanoma Of Soft Tissues, which biomarkers have evidence?",✓,✓,✗,5,0,
